Health
Genetically engineered intestinal organoids reveal potential treatment targets against SARS-CoV-2 – News-Medical.Net
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers…
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers from the Netherlands identified a specific serine protease (TMPRSS2) as an attractive pan-coronavirus therapeutic target. Their exciting findings are available in a study currently available on the bioRxiv* preprint server.
The current coronavirus disease (COVID-19) pandemic, caused by the SARS-CoV-2, has exposed earnest weaknesses…
-
Noosa News13 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General23 hours agoUS authorities to set targets to lower medicine prices
-
Noosa News20 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common
-
Noosa News12 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash